The Bivalent Ligand Approach Leads to Highly Potent and Selective Acylguanidine-Type Histamine H2 Receptor Agonists-Reference-Cited by-同舟云学术

The Bivalent Ligand Approach Leads to Highly Potent and Selective Acylguanidine-Type Histamine H2 Receptor Agonists

Published:2012-01-25 Issue:3 Volume:55 Page:1147-1160
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Birnkammer Tobias¹,Spickenreither Anja¹,Brunskole Irena¹,Lopuch Miroslaw¹,Kagermeier Nicole¹,Bernhardt Günther¹,Dove Stefan¹,Seifert Roland²,Elz Sigurd¹,Buschauer Armin¹

Affiliation:

1. Department of Pharmaceutical/Medicinal Chemistry, Faculty of Chemistry and Pharmacy, University of Regensburg, Universitätsstrasse 31, D-93053 Regensburg, Germany

2. Institute of Pharmacology, Medical School of Hannover, D-30625 Hannover, Germany

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm201128q

Reference76 articles.

1. Definition and Antagonism of Histamine H2-receptors

2. The histamine H2-receptor agonist impromidine: synthesis and structure activity considerations

3. Synthesis and in vitro pharmacology of arpromidine and related phenyl(pyridylalkyl)guanidines, a potential new class of positive inotropic drugs

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Designing drugs and chemical probes with the dualsteric approach;Chemical Society Reviews;2023

2. Recent Advances in Dopamine D3 Receptor Heterodimers: Focus on Dopamine D3 and D1 Receptor–Receptor Interaction and Striatal Function;Therapeutic Applications of Dopamine D3 Receptor Function;2022

3. The Roles of Cardiovascular H2-Histamine Receptors Under Normal and Pathophysiological Conditions;Frontiers in Pharmacology;2021-12-20

4. Shining light on the histamine H2 receptor: Synthesis of carbamoylguanidine-type agonists as a pharmacological tool to study internalization;Bioorganic & Medicinal Chemistry Letters;2021-11

5. Abolishing Dopamine D2long/D3 Receptor Affinity of Subtype-Selective Carbamoylguanidine-Type Histamine H2 Receptor Agonists;Journal of Medicinal Chemistry;2021-06-10